Brain Neoplasms

Home
About
Help
History (1)
- Brain Neoplasms
- See All Pages

"Brain Neoplasms" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

Neoplasms of the intracranial components of the central nervous system, including the cerebral hemispheres, basal ganglia, hypothalamus, thalamus, brain stem, and cerebellum. Brain neoplasms are subdivided into primary (originating from brain tissue) and secondary (i.e., metastatic) forms. Primary neoplasms are subdivided into benign and malignant forms. In general, brain tumors may also be classified by age of onset, histologic type, or presenting location in the brain.

Descriptor ID	D001932
MeSH Number(s)	C04.588.614.250.195 C10.228.140.211 C10.551.240.250
Concept/Terms	Brain Neoplasms Brain Neoplasms Neoplasms, Brain Brain Neoplasm Neoplasm, Brain Brain Tumors Brain Tumor Tumor, Brain Tumors, Brain Brain Cancer Brain Cancer Brain Cancers Cancer, Brain Cancers, Brain Malignant Neoplasms, Brain Brain Malignant Neoplasm Brain Malignant Neoplasms Malignant Neoplasm, Brain Cancer of Brain Cancer of the Brain Neoplasms, Brain, Malignant Brain Neoplasms, Malignant Brain Neoplasm, Malignant Malignant Brain Neoplasm Malignant Brain Neoplasms Neoplasms, Intracranial Neoplasms, Intracranial Intracranial Neoplasm Neoplasm, Intracranial Intracranial Neoplasms Brain Tumor, Recurrent Brain Tumor, Recurrent Brain Tumors, Recurrent Recurrent Brain Tumor Recurrent Brain Tumors Malignant Primary Brain Tumors Malignant Primary Brain Tumors Primary Malignant Brain Tumors Malignant Primary Brain Neoplasms Primary Malignant Brain Neoplasms Brain Neoplasms, Malignant, Primary Brain Neoplasms, Primary Malignant Benign Neoplasms, Brain Benign Neoplasms, Brain Benign Neoplasm, Brain Brain Benign Neoplasm Brain Benign Neoplasms Neoplasms, Brain, Benign Brain Neoplasms, Benign Benign Brain Neoplasm Benign Brain Neoplasms Brain Neoplasm, Benign Brain Tumor, Primary Brain Tumor, Primary Brain Tumors, Primary Primary Brain Tumor Primary Brain Tumors Neoplasms, Brain, Primary Brain Neoplasm, Primary Brain Neoplasms, Primary Primary Brain Neoplasm Primary Brain Neoplasms

Below are MeSH descriptors whose meaning is more general than "Brain Neoplasms".

Diseases [C]
Neoplasms [C04]
Neoplasms by Site [C04.588]
Nervous System Neoplasms [C04.588.614]
Central Nervous System Neoplasms [C04.588.614.250]
Brain Neoplasms [C04.588.614.250.195]
Nervous System Diseases [C10]
Central Nervous System Diseases [C10.228]
Brain Diseases [C10.228.140]
Brain Neoplasms [C10.228.140.211]
Nervous System Neoplasms [C10.551]
Central Nervous System Neoplasms [C10.551.240]
Brain Neoplasms [C10.551.240.250]

Below are MeSH descriptors whose meaning is more specific than "Brain Neoplasms".

publications

Timeline | Most Recent

This graph shows the total number of publications written about "Brain Neoplasms" by people in this website by year, and whether "Brain Neoplasms" was a major or minor topic of these publications.

Bar chart showing 264 publications over 28 distinct years, with a maximum of 24 publications in 2015

To see the data from this visualization as text, click here.

Year	Major Topic	Minor Topic	Total
1996	2	2	4
1998	4	2	6
1999	2	1	3
2000	6	1	7
2001	7	0	7
2002	7	0	7
2003	4	0	4
2004	6	2	8
2005	9	3	12
2006	4	1	5
2007	8	3	11
2008	6	1	7
2009	5	1	6
2010	11	1	12
2011	9	4	13
2012	11	0	11
2013	3	1	4
2014	13	1	14
2015	22	2	24
2016	10	2	12
2017	14	3	17
2018	11	0	11
2019	7	1	8
2020	13	1	14
2021	11	2	13
2022	8	1	9
2023	4	0	4
2024	11	0	11

Below are the most recent publications written about "Brain Neoplasms" by people in Profiles.

Bowers DC, Johnson MD. Feasibility of transcranial Doppler to evaluate vasculopathy among survivors of childhood brain tumors exposed to cranial radiation therapy. Pediatr Blood Cancer. 2025 Jan; 72(1):e31392.

View in: PubMed
Forst DA, Podgurski AF, Strander SM, Whitman JD, Datta S, Pintro K, Horick NK, Willis KD, Sannes TS, Greer JA, El-Jawahri A, Jacobs JM, Temel JS. NeuroCARE: A Randomized Controlled Trial of a Psychological Intervention for Caregivers of Patients With Primary Malignant Brain Tumors. J Clin Oncol. 2024 Dec 20; 42(36):4252-4262.

View in: PubMed
Moskal P, Baran J, Bass S, Choinski J, Chug N, Curceanu C, Czerwinski E, Dadgar M, Das M, Dulski K, Eliyan KV, Fronczewska K, Gajos A, Kacprzak K, Kajetanowicz M, Kaplanoglu T, Kaplon L, Klimaszewski K, Kobylecka M, Korcyl G, Kozik T, Krzemien W, Kubat K, Kumar D, Kunikowska J, Maczewska J, Migdal W, Moskal G, Mryka W, Niedzwiecki S, Parzych S, Del Rio EP, Raczynski L, Sharma S, Shivani S, Shopa RY, Silarski M, Skurzok M, Tayefi F, Ardebili KT, Tanty P, Wislicki W, Kr?licki L, Stepien EL. Positronium image of the human brain in vivo. Sci Adv. 2024 Sep 13; 10(37):eadp2840.

View in: PubMed
Sarli SL, Fakih HH, Kelly K, Devi G, Rembetsy-Brown JM, McEachern HR, Ferguson CM, Echeverria D, Lee J, Sousa J, Sleiman HF, Khvorova A, Watts JK. Quantifying the activity profile of ASO and siRNA conjugates in glioblastoma xenograft tumors in vivo. Nucleic Acids Res. 2024 May 22; 52(9):4799-4817.

View in: PubMed
Kim AE, Lou KW, Giobbie-Hurder A, Chang K, Gidwani M, Hoebel K, Patel JB, Cleveland MC, Singh P, Bridge CP, Ahmed SR, Bearce BA, Liu W, Fuster-Garcia E, Lee EQ, Lin NU, Overmoyer B, Wen PY, Nayak L, Cohen JV, Dietrich J, Eichler A, Heist R, Krop I, Lawrence D, Ligibel J, Tolaney S, Mayer E, Winer E, Perrino CM, Summers EJ, Mahar M, Oh K, Shih HA, Cahill DP, Rosen BR, Yen YF, Kalpathy-Cramer J, Martinez-Lage M, Sullivan RJ, Brastianos PK, Emblem KE, Gerstner ER. Abnormal vascular structure and function within brain metastases is linked to pembrolizumab resistance. Neuro Oncol. 2024 05 03; 26(5):965-974.

View in: PubMed
Tropeano MP, Raspagliesi L, Bono BC, Baram A, Rossini Z, Franzini A, Navarria P, Clerici E, Bellu L, Simonelli M, Scorsetti M, Riva M, Politi LS, Pessina F. Supramaximal resection: retrospective study on IDH-wildtype Glioblastomas based on the new RANO-Resect classification. Acta Neurochir (Wien). 2024 Apr 27; 166(1):196.

View in: PubMed
Kumar VA, Lee J, Liu HL, Allen JW, Filippi CG, Holodny AI, Hsu K, Jain R, McAndrews MP, Peck KK, Shah G, Shimony JS, Singh S, Zeineh M, Tanabe J, Vachha B, Vossough A, Welker K, Whitlow C, Wintermark M, Zaharchuk G, Sair HI. Recommended Resting-State fMRI Acquisition and Preprocessing Steps for Preoperative Mapping of Language and Motor and Visual Areas in Adult and Pediatric Patients with Brain Tumors and Epilepsy. AJNR Am J Neuroradiol. 2024 02 07; 45(2):139-148.

View in: PubMed
Bono BC, Ninatti G, Riva M, Raspagliesi L, Barbieri EM, Navarria P, Clerici E, Politi LS, Simonelli M, Rodari M, Sollini M, Chiti A, Pessina F. The role of preoperative [11C]methionine PET in defining tumor-related epilepsy and predicting short-term postoperative seizure control in temporal lobe low-grade gliomas. Neurosurg Focus. 2024 02; 56(2):E6.

View in: PubMed
Yekula A, Gessler DJ, Ferreira C, Shah R, Reynolds M, Dusenbery K, Chen CC. GammaTile? (GT) as a brachytherapy platform for rapidly proliferating glioblastomas: from case series to clinical trials. J Neurooncol. 2024 Feb; 166(3):441-450.

View in: PubMed
Nayyar N, de Sauvage MA, Chuprin J, Sullivan EM, Singh M, Torrini C, Zhang BS, Bandyopadhyay S, Daniels KA, Alvarez-Breckenridge C, Dahal A, Brehm MA, Brastianos PK. CDK4/6 Inhibition Sensitizes Intracranial Tumors to PD-1 Blockade in Preclinical Models of Brain Metastasis. Clin Cancer Res. 2024 01 17; 30(2):420-435.

View in: PubMed

People

Explore

Similar Concepts

Top Journals